Spotlight Innovation Income from Discontinued Operations 2010-2018 | STLT

Spotlight Innovation income from discontinued operations from 2010 to 2018. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
Spotlight Innovation Annual Income from Discontinued Operations
(Millions of US $)
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Spotlight Innovation Quarterly Income from Discontinued Operations
(Millions of US $)
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2012-12-31
2011-12-31
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
Spotlight Innovation Inc. is involved in identifying, validating and cooperating with companies developing healthcare technologies which consist of pharmaceuticals, devices and equipment, diagnostic products and healthcare IT. Spotlight Innovation Inc. is based in West Des Moines, Iowa.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.604B 21.88
Becton Dickinson (BDX) United States $50.274B 12.45
Cardinal Health (CAH) United States $36.816B 19.28
Straumann Holding AG (SAUHY) Switzerland $21.909B 0.00
Labcorp (LH) United States $20.885B 16.94
Cooper (COO) United States $16.582B 22.00
West Pharmaceutical Services (WST) United States $15.565B 32.63
Align Technology (ALGN) United States $13.648B 27.09
Henry Schein (HSIC) United States $8.770B 15.04
Merit Medical Systems (MMSI) United States $5.841B 28.24
DENTSPLY SIRONA (XRAY) United States $3.328B 9.94
CONMED (CNMD) United States $1.865B 13.96
STAAR Surgical (STAA) United States $0.952B 0.00
Lifevantage (LFVN) United States $0.169B 17.39
Pro-Dex (PDEX) United States $0.141B 15.40